Core Insights - The aging population is a significant long-term investment theme in healthcare, particularly benefiting healthcare real estate and senior care services alongside traditional pharmaceutical and biotech sectors [2] - Demand for senior housing, assisted living, rehabilitation, and long-term care facilities is increasing due to the growing population aged 60 and above, positioning healthcare REITs and senior care operators favorably within the longevity economy [2] Healthcare REITs - Healthcare REITs and operators manage properties and services that generate stable, demographic-driven cash flows, with the senior housing industry expanding due to aging populations and rising life expectancy [4] - Limited new construction in senior housing due to high financing and construction costs is supporting occupancy growth and rental income for existing properties [4][5] - Companies like Welltower and Ventas are increasing their exposure to senior housing, aligning their long-term growth strategies with demographic-driven demand [5] Operators and Care-Focused REITs - Companies such as Ensign, Omega, and CareTrust are directly linked to the care needs of an aging population, with sustained demand for skilled nursing and long-term care services driven by longer life expectancy [6] - Ensign operates skilled nursing and senior living facilities, while Omega and CareTrust lease facilities to operators, focusing on essential care capacity and service delivery [7] Company-Specific Insights - Ventas is engaged in acquiring and leasing senior housing communities and reported strong performance in its senior housing operating portfolio, with significant occupancy gains and cash NOI growth [10][11] - Welltower has launched a private funds management business, closing its inaugural fund with approximately $2.5 billion in equity commitments, positioning its portfolio for long-term growth [13] - CareTrust has expanded its portfolio through acquisitions aligned with aging demographics, including skilled nursing and senior housing properties, enhancing its exposure to long-term care real estate [15][16] - Omega reported continued investment activity with approximately $334 million in new investments, showcasing improved operating metrics and portfolio growth tied to the aging population [18][19]

Core Viewpoint - Healthpeak (DOC) is undervalued in the market, particularly regarding its senior housing assets, which are being spun off into a new entity, Janus Living (JAN), to unlock their true value [1][2][29]. Valuation Overview - Healthpeak's property valuation includes $10.5 billion in medical office buildings (MOBs), $8.8 billion in labs, and approximately $3 billion in senior housing [3]. - The senior housing portfolio is believed to be worth $4.25 billion, significantly higher than the $3 billion recorded on the books [2][12]. Market Comparisons - The market multiples for different property sectors show that labs trade at the lowest multiples, while senior housing commands the highest [5][8]. - Healthpeak trades at 11.3X AFFO, which is between the multiples for labs (10.3X) and MOBs (14.6X), indicating a lack of recognition for its senior housing assets [8][11]. Upcoming IPO Details - The IPO for Janus Living is targeting a price range of $18-$20 per share, with strong investor interest already indicated [13][14]. - The offering aims to raise approximately $635.5 million in net proceeds, with Healthpeak retaining a significant ownership stake in Janus [15][17]. Financial Metrics - The implied valuation of Janus at the midpoint offering price of $19 suggests a total value of approximately $4.79 billion, with senior housing assets valued at around $4.26 billion after accounting for cash and debt [19][21]. - The pro forma estimated NOI for the senior housing portfolio is $199.6 million, with an AFFO of $170 million [25]. Future Growth Potential - Janus Living is expected to utilize IPO proceeds for immediate acquisitions, positioning it for growth [30]. - Healthpeak will benefit from the value appreciation of Janus shares, which will be held on its balance sheet for at least a year due to lock-up provisions [32].

Summary of American Healthcare REIT (NYSE:AHR) Conference Call Company Overview - **Company**: American Healthcare REIT (AHR) - **Industry**: Senior housing and long-term care real estate investment trust (REIT) Key Points and Arguments Market Position and Growth - AHR operates in a favorable segment of real estate focused on senior housing and long-term care, with strong supply and demand fundamentals [3][6] - The company projects nearly 18% growth in NFFO (Normalized Funds From Operations) per share, indicating robust organic earnings growth [3][4] - AHR maintains a safe balance sheet with a net debt to EBITDA ratio of 3.4 times, allowing for continued growth [5] Demand Drivers - The aging population is a significant driver, with 10,000 people turning 80 daily, increasing the demand for assisted living and skilled nursing services [6][7] - Less than 1% of the total stock in the sector is currently under construction, suggesting limited new supply and sustained growth potential [7] Trilogy Segment - Trilogy, which constitutes 60% of AHR's portfolio, is a unique integrated campus model combining skilled nursing, assisted living, and independent living, providing a continuum of care [15][22] - Trilogy has a competitive advantage due to its high-quality operations, evidenced by a four-star CMS rating, which attracts partnerships with Medicare Advantage plans [10][11][22] Revenue Growth Strategies - AHR is focused on optimizing the mix of payment sources, shifting towards higher reimbursement sources like Medicare and Medicare Advantage, which has led to over 8.5% growth in that segment [12][13] - The company emphasizes the importance of selecting high-quality operators and has a rigorous process for underwriting new operators, preferring regional operators for their market expertise [30][31] Operational Efficiency - AHR aims to improve operating margins by reducing reliance on agency labor and enhancing employee satisfaction, which is linked to resident care quality [46][51] - The company is exploring AI and technology to improve labor efficiencies and predictive analytics for better care management [49][54] Market Outlook - AHR anticipates a potential shortfall of 576,000 senior housing units by 2030, with a projected development cost of $275 billion, indicating a significant opportunity for growth [35] - The company expects construction to pick up around 2027-2028, as current conditions do not favor new developments [62][63] Regulatory Environment - The current regulatory landscape appears stable, with no immediate concerns regarding funding cuts for skilled nursing, which could threaten the industry [60][61] Additional Important Insights - AHR's focus on assisted living over independent living is strategic, as assisted living is more needs-based and less affected by economic downturns [40][41] - The average length of stay in assisted living is about two years, which supports occupancy rates and revenue generation [56] - AHR's management contract with Trilogy is designed to align incentives closely with performance, enhancing operational efficiency and profitability [24][25] This summary encapsulates the key insights from the conference call, highlighting the company's strategic positioning, growth potential, and operational focus within the senior housing sector.

Core Viewpoint - Ventas is positioned as a leading company in the longevity economy, focusing on serving the growing aging population, with a strong emphasis on senior housing as a key growth driver [2][3]. Company Overview - Ventas is an S&P 500 company with an enterprise value exceeding $50 billion and operates approximately 1,400 properties [2][3]. - The company’s senior housing segment constitutes more than half of its business and is projected to achieve its fifth consecutive year of double-digit Net Operating Income (NOI) growth in its Senior Housing Operating Portfolio (SHOP) this year [3].

Investor Presentation February 2026 1 1 Overture at Plano 500 Coit Road Plano, TX Warning Concerning Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as "believe", "expect", "anticipate", "intend", "plan", "estimate", "will", "may" and negatives or derivatives of these or similar expressions. ...

Core Viewpoint - National Healthcare Properties, Inc. reported strong internal growth in its senior housing portfolio and steady performance in its outpatient medical portfolio for the year 2025, indicating robust fundamentals in the healthcare real estate industry, particularly in the senior housing sector [2]. Financial Performance and Other Highlights - For Q4 2025, the company reported a net loss attributable to common stockholders of $(25.978) million, or $(0.92) per share, compared to a net loss of $(20.437) million, or $(0.72) per share in Q4 2024 [9]. - Funds From Operations (FFO) for Q4 2025 was $2.092 million, or $0.07 per diluted share, a decrease of 49.1% year-over-year, while Normalized FFO was $5.849 million, or $0.20 per diluted share, a decrease of 12.8% year-over-year [9]. - The Same Store Cash Net Operating Income (NOI) growth for Q4 2025 was 9.8% year-over-year, with the Senior Housing Operating Property (SHOP) segment showing a significant growth of 26.5% [9]. - For the full year 2025, the portfolio Same Store Cash NOI growth was 9.0% year-over-year, with SHOP segment growth at 21.8% and Outpatient Medical Facility (OMF) segment growth at 2.9% [9]. Balance Sheet and Capital - As of December 31, 2025, the total debt outstanding was approximately $1.0 billion, with a weighted average economic interest rate of 5.75% and an average remaining term of 3.9 years [5]. - The company entered into a $400 million senior unsecured revolving credit facility and a $150 million senior unsecured term loan, both maturing in December 2028, to refinance a previous $330 million secured term loan [6]. - The Net Leverage ratio improved to 9.2x as of December 31, 2025, down from 10.3x as of December 31, 2024 [7]. Dispositions and Dividends - In 2025, the company completed dispositions totaling $202.5 million, which included the sale of seven Non-Core SHOPs and 18 Non-Core OMFs [9]. - The Board of Directors declared dividends on the company's preferred stock, with a total repurchase of previously outstanding preferred stock amounting to approximately $8.6 million at a weighted average yield of 11.5% [10][14].

Financial Data and Key Metrics Changes - Sabra's normalized FFO per share for Q4 2025 was $0.36, and normalized AFFO per share was $0.38, totaling $91.2 million and $95.2 million respectively for the quarter [12][15] - Cash NOI from the triple net portfolio decreased by $1.3 million sequentially, while cash NOI from the managed senior housing portfolio increased by $5.5 million, resulting in a net increase of $4.2 million [12][13] - The net debt to adjusted EBITDA ratio was 5.00 times as of December 31, 2025, a decrease of 0.27 times from the previous year [17] Business Line Data and Key Metrics Changes - The managed senior housing portfolio experienced a revenue growth of 15.8% and cash NOI growth of 18.4%, with margin expansion of 60 basis points [8] - The same-store managed senior housing portfolio saw a revenue increase of 6.4% year-over-year, with occupancy rising by 160 basis points to 87.9% [10] - The skilled nursing portfolio achieved an all-time high in rent coverage and increased occupancy [7] Market Data and Key Metrics Changes - The Canadian communities within the same-store portfolio grew revenue by 10% year-over-year, with occupancy increasing by 300 basis points to 94.2% [10] - The domestic portfolio occupancy increased by 80 basis points to 84.7% during the same period [10] Company Strategy and Development Direction - The company expects strong NOI growth for the SHOP portfolio in 2026, with guidance for normalized FFO and AFFO growth at 4.9%-5.4% [5] - Sabra's investment activity is projected to exceed the volume of 2025 investments, with a robust pipeline and $240 million of awarded deals expected to close in Q1 and early Q2 2026 [6][9] - The company continues to focus on SHOP investments, which represent approximately 95% of the investment opportunities being pursued [39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational performance and growth prospects, citing industry tailwinds and a robust pipeline [10] - The regulatory environment remains stable, and management does not foresee significant changes impacting operations [7][82] - The company anticipates continued occupancy growth in the same-store portfolio, aiming for low 90s occupancy levels [24] Other Important Information - The board declared a quarterly cash dividend of $0.30 per common share, representing a payout of 79% of the fourth quarter normalized AFFO per share [20] - The company has ample liquidity of approximately $1.2 billion, consisting of cash and available borrowings [19] Q&A Session Summary Question: Can you provide insights on same-store growth and long-term prospects? - Management expects continued occupancy growth in the same-store portfolio, aiming for low 90s occupancy levels, with potential for rate growth [24][25] Question: What is the status of the RCA loan and tenant health? - The RCA loan is being serviced appropriately, and discussions with the equity sponsor are ongoing, indicating tenant health is stable [27][30] Question: What are the expectations for maintenance CapEx in 2026? - Maintenance CapEx is expected to remain at similar levels, with non-maintenance CapEx projected in the $20-$30 million range [32] Question: How is the investment landscape changing? - The investment activity is significantly weighted towards SHOP, with continued competition but opportunities for high-quality assets at good yields [58] Question: What is the outlook for occupancy growth in Canada? - The Canadian portfolio is expected to continue its growth trajectory, with lower construction rates compared to the U.S. market [52] Question: How does the company view the complexity of operating in the SHOP space? - Management acknowledges the complexities of operating in the SHOP space, emphasizing the importance of experienced operators and continuous improvement in management practices [88][91]

Core Insights - Ventas, Inc. reported strong growth in 2025, particularly in its senior housing portfolio, with Same-Store Cash NOI increasing by over 15% driven by occupancy gains and higher revenue per occupied room [1][2] - The company completed $2.5 billion in senior housing investments and raised $3.2 billion in equity, maintaining a robust balance sheet with $5.3 billion in liquidity and a Net Debt-to-Adjusted EBITDA ratio of 5.2x [1][2] - For 2026, Ventas anticipates continued growth in the SHOP segment, projecting net income of $0.57 per share and normalized FFO of $3.83, an 8% increase on a comparable basis [3] Financial Performance - Fourth-quarter results showed net income of $0.15 per share and normalized FFO of $0.89 per share, reflecting a 10% increase from the previous year [2] - Full-year results included net income of $0.54 per share and normalized FFO of $3.48, with total company NOI growth of 16% [2] - The company declared a quarterly dividend of $0.52 per share, marking an 8% increase [2] Future Outlook - Ventas plans to invest approximately $2.5 billion in senior housing in 2026, with early activity already including over $0.8 billion in acquisitions [3] - The company updated its FFO calculation methodology to exclude non-cash stock-based compensation, aligning with industry standards [3] Company Overview - Ventas, Inc. is a leading S&P 500 REIT that owns and manages a diverse portfolio of over 1,200-1,400 healthcare and senior living properties across the U.S., Canada, and the U.K. [4] - The company focuses on investing in senior housing, medical office buildings, and research/innovation centers to support the aging population [4]

Core Insights - Ventas, Inc. (VTR) is a healthcare REIT with a market cap of $36.1 billion, focusing on senior housing, medical office buildings, life science facilities, and healthcare-related properties [1] - The company is expected to announce its fiscal Q4 earnings for 2025 soon, with analysts predicting a profit of $0.89 per share, a 9.9% increase from the previous year [2] - Ventas has consistently exceeded Wall Street's bottom-line estimates for the last four quarters, with a forecasted FFO of $3.48 per share for the current fiscal year, representing a 9.1% increase from fiscal 2024 [3] Financial Performance - In Q3, Ventas reported total revenue of $1.5 billion, a 20.4% year-over-year increase, surpassing consensus estimates by 4.2% [5] - The company's normalized FFO for Q3 was $0.88, which improved 10% from the same quarter last year, exceeding analyst expectations [5] - The strong performance was attributed to the senior housing operating portfolio (SHOP), which saw double-digit organic growth year-over-year [5] Market Performance - Over the past 52 weeks, Ventas shares have increased by 32.6%, outperforming the S&P 500 Index's 19.3% return and the State Street Real Estate Select Sector SPDR ETF's 2.3% increase [4] - Wall Street analysts have a highly optimistic outlook for VTR, with a "Strong Buy" rating from 16 out of 21 analysts, and a mean price target of $86.40, indicating a 12.3% potential upside [6]

Core Insights - Welltower, Inc. (WELL) and Medical Properties (MPW) are significant players in the healthcare real estate investment trust (REIT) sector, with differing strategies and structures [1][2] - The choice between these two REITs reflects a preference for growth (Welltower) versus stable income (Medical Properties) [3] Group 1: Welltower Overview - Welltower focuses on senior housing, outpatient medical, and post-acute care properties across the U.S., U.K., and Canada, operating over 2,000 senior and wellness housing communities [4] - The company anticipates sustained occupancy growth in its senior housing operating (SHO) portfolio due to a supply-demand imbalance, leading to multi-year revenue growth [5] - Welltower employs "triple net" leases, insulating itself from short-term market fluctuations and ensuring steady revenue growth [6] - The company actively engages in capital recycling to finance investments and development opportunities, enhancing long-term growth prospects [7] - Welltower maintains a strong balance sheet with ample liquidity and favorable credit ratings, allowing access to debt markets under favorable conditions [8] Group 2: Medical Properties Overview - Medical Properties focuses on acquiring and developing net-leased healthcare facilities, with a portfolio of 388 properties and approximately 39,000 licensed beds leased to 51 hospital operating companies [10] - The company relies on long-term net-leased hospitals with CPI-linked rent escalations to ensure stable rental income [11] - Medical Properties actively manages operator concentration risk and employs a disciplined capital-recycling strategy to enhance liquidity and financial flexibility [13][14] - Despite significant debt levels, the company’s disciplined financial management supports ongoing operations [15] Group 3: Financial Estimates and Performance - The Zacks Consensus Estimate for Welltower's 2025 sales and funds from operations (FFO) per share indicates year-over-year growth of 29.8% and 21.5%, respectively [16] - In contrast, Medical Properties' estimates for 2025 sales and FFO per share suggest a decline of 5.1% and 31.3%, respectively [18] - Over the past three months, Welltower shares have increased by 6.5%, while Medical Properties stock has risen by 2%, outperforming the Zacks REIT and Equity Trust - Other industry, which decreased by 1.4% [21] - Welltower is trading at a forward price-to-FFO of 30.97X, above its three-year median, while Medical Properties is at 7.71X, also above its three-year median [22] Group 4: Conclusion - Welltower and Medical Properties both benefit from strong healthcare sector demand but offer different investment profiles, with Welltower positioned for growth and Medical Properties for stable income [25] - Welltower's favorable demographic trends, investment-grade credit ratings, and healthy balance sheet provide it with a competitive edge [25] - For investors seeking long-term growth, Welltower is currently viewed as the more attractive healthcare REIT option [26]